Fresnillo (LSE: FRES): Can the world’s largest silver miner hold its record gains as 2026 output dips?
TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News AHA 2025: New REDUCE-IT results reveal Vascepa lowers heart attack and stroke risk even when LDL-C is optimal Find out how AHA 2025 REDUCE-IT results show Vascepa reduces heart attack and stroke risk even when LDL-C is optimal — reshaping cardiovascular prevention. bySoujanya RaviNovember 10, 2025